MUC16 and ovarian cancer: In a study by Tcherkassova et al., the receptor for circulating fetal protein alpha-fetoprotein (RECAF), an oncofetal antigen, has been examined as a biomarker for early detection of ovarian cancer in conjunction with CA125 among healthy women.